Calvin Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Calvin Huang has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Hamid Shokoohi
Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
6 shared publications - Andrew Liteplo
Department of Emergency Medicine Massachusetts General Hospital Boston Massachusetts USA
3 shared publications - Andrew Goldsmith
Department of Emergency Medicine, Lahey Hospital, Burlington, USA
2 shared publications - Andrew S. Liteplo
Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA
2 shared publications - Irene Wai Yan Ma
Department of Medicine, University of Calgary, Calgary, Canada
2 shared publications - Nicole M. Duggan
Department of Emergency Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
2 shared publications
Latest Publications
- Open Access
Supplemental oxygen for pulmonary embolism (SO-PE): study protocol for a mechanistic, randomised, blinded, cross-over study
Background: Acute pulmonary embolism (PE) mortality is linked to abrupt rises in pulmonary artery (PA) pressure due to mechanical obstruction and pulmonary vasoconstriction, leading to right ventricular (RV) dilation, increased RV wall tension and oxygen demand, but compromised right coronary artery oxygen supply. Oxygen is a known pulmonary vasodilator, and in preclinical animal models of PE, supplemental oxygen reduces PA pressures and improves RV function. However, the mechanisms driving these interactions, especially in humans, remain poorly understood. The overall objective of the supplemental oxygen in pulmonary embolism (SO-PE) study is to investigate the mechanisms of supplemental oxygen in patients with acute PE. Methods and analysis: This randomised, double-blind, cross-over trial at Massachusetts General Hospital will include adult patients with acute PE and evidence of RV dysfunction but without hypoxaemia (SaO 2 ≥90% on room air). We will enrol 80 patients, each serving as their own control, with 40 randomised to start on supplemental oxygen, and 40 randomised to start on room air. Over 180 min, patients will alternate between supplemental oxygen delivered by non-rebreather mask (60% FiO 2 ) and room air (21% FiO 2 ). The primary outcome will be the difference in pulmonary artery systolic pressure with and without oxygen. Secondary outcomes include additional echocardiographic measures, metabolomic profiles, vital signs and dyspnoea scores. Echocardiographic data will be compared by a paired t-test or Wilcoxon signed-rank test. For metabolomic analyses, we will perform multivariable mixed effects logistic regression models and calculate false discovery rate (q-value ≤0.05) to account for multiple comparisons. Data will be collected in compliance with National Institutes of Health and National Heart Lung and Blood Institute (NHLBI) policies for data and safety monitoring. Ethics and dissemination: The SO-PE study is funded by the NHLBI and has been approved by the Institutional Review Board of Mass General Brigham (no. 2023P000252). The study will comply with the Helsinki Declaration on medical research involving human subjects. All participants will provide prospective, written informed consent. Trial registration number: NCT05891886 .
Open AccessSupplemental oxygen for pulmonary embolism (SO-PE): study protocol for a mechanistic, randomised, blinded, cross-over study
Background: Acute pulmonary embolism (PE) mortality is linked to abrupt rises in pulmonary artery (PA) pressure due to mechanical obstruction and pulmonary vasoconstriction, leading to right ventricular (RV) dilation, increased RV wall tension and oxygen demand, but compromised right coronary artery oxygen supply. Oxygen is a known pulmonary vasodilator, and in preclinical animal models of PE, supplemental oxygen reduces PA pressures and improves RV function. However, the mechanisms driving these interactions, especially in humans, remain poorly understood. The overall objective of the supplemental oxygen in pulmonary embolism (SO-PE) study is to investigate the mechanisms of supplemental oxygen in patients with acute PE. Methods and analysis: This randomised, double-blind, cross-over trial at Massachusetts General Hospital will include adult patients with acute PE and evidence of RV dysfunction but without hypoxaemia (SaO 2 ≥90% on room air). We will enrol 80 patients, each serving as their own control, with 40 randomised to start on supplemental oxygen, and 40 randomised to start on room air. Over 180 min, patients will alternate between supplemental oxygen delivered by non-rebreather mask (60% FiO 2 ) and room air (21% FiO 2 ). The primary outcome will be the difference in pulmonary artery systolic pressure with and without oxygen. Secondary outcomes include additional echocardiographic measures, metabolomic profiles, vital signs and dyspnoea scores. Echocardiographic data will be compared by a paired t-test or Wilcoxon signed-rank test. For metabolomic analyses, we will perform multivariable mixed effects logistic regression models and calculate false discovery rate (q-value ≤0.05) to account for multiple comparisons. Data will be collected in compliance with National Institutes of Health and National Heart Lung and Blood Institute (NHLBI) policies for data and safety monitoring. Ethics and dissemination: The SO-PE study is funded by the NHLBI and has been approved by the Institutional Review Board of Mass General Brigham (no. 2023P000252). The study will comply with the Helsinki Declaration on medical research involving human subjects. All participants will provide prospective, written informed consent. Trial registration number: NCT05891886 .
- Open Access
- 11 January 2022
- Published by Elsevier in JACEP Open
- Vol. 3 (1) , e12645
Advanced practice providers proficiency‐based model of ultrasound training and practice in the ED
- 11 January 2022
- Published by Elsevier in JACEP Open
- Vol. 3 (1) , e12645
Open AccessAdvanced practice providers proficiency‐based model of ultrasound training and practice in the ED
- Open Access
- 11 January 2022
- Published by Springer Nature in Cureus
- Vol. 14 (1) , e21116
Point-of-Care Lung Ultrasound for Differentiating COVID-19 From Influenza
Patients infected with influenza and COVID-19 exhibit similar clinical presentations; thus, a point-of-care test to differentiate between the diseases is needed. Here, we sought to identify features of point-of-care lung ultrasound (LUS) that can discriminate between influenza and COVID-19. In this prospective, cross-sectional study, LUS clips of patients presenting to the emergency department (ED) with viral-like symptoms were collected via a 10-zone scanning protocol. Deidentified clips were interpreted by emergency ultrasound fellows blinded to patients’ clinical context and influenza or COVID-19 diagnosis. Modified Soldati scores were calculated for each lung zone. Logistic regression identified the association of pulmonary pathologies with each disease. Ultrasound fellows reviewed LUS clips from 165 patients, of which 30.9% (51/165) had confirmed influenza, 33.9% (56/165) had confirmed COVID-19, and 35.1% (58/165) had neither disease. Patients with COVID-19 were more likely to have irregular pleura and B-lines in all lung zones (p<0.01). The median-modified Soldati score for influenza patients was 0/20 (IQR 0-2), 9/20 (IQR 2.5-15.5) for COVID-19 patients, and 2/20 (IQR 0-8) for patients with neither disease (p<0.0001). In multivariate regression analysis adjusted for age, sex, and congestive heart failure (CHF), the presence of B-lines (OR = 1.29, 95% CI 1.09-1.53) was independently associated with COVID-19 diagnosis. The presence of pleural effusion was inversely associated with COVID-19 (OR = 0.09, 95% CI 0.01-0.65). LUS may help providers preferentially identify the presence of influenza versus COVID-19 infection both visually and by calculating a modified Soldati score. Further studies assessing the utility of LUS in differentiating viral illnesses in patients with variable illness patterns and those with variable illness severity are warranted.
- 11 January 2022
- Published by Springer Nature in Cureus
- Vol. 14 (1) , e21116
Open AccessPoint-of-Care Lung Ultrasound for Differentiating COVID-19 From Influenza
Patients infected with influenza and COVID-19 exhibit similar clinical presentations; thus, a point-of-care test to differentiate between the diseases is needed. Here, we sought to identify features of point-of-care lung ultrasound (LUS) that can discriminate between influenza and COVID-19. In this prospective, cross-sectional study, LUS clips of patients presenting to the emergency department (ED) with viral-like symptoms were collected via a 10-zone scanning protocol. Deidentified clips were interpreted by emergency ultrasound fellows blinded to patients’ clinical context and influenza or COVID-19 diagnosis. Modified Soldati scores were calculated for each lung zone. Logistic regression identified the association of pulmonary pathologies with each disease. Ultrasound fellows reviewed LUS clips from 165 patients, of which 30.9% (51/165) had confirmed influenza, 33.9% (56/165) had confirmed COVID-19, and 35.1% (58/165) had neither disease. Patients with COVID-19 were more likely to have irregular pleura and B-lines in all lung zones (p<0.01). The median-modified Soldati score for influenza patients was 0/20 (IQR 0-2), 9/20 (IQR 2.5-15.5) for COVID-19 patients, and 2/20 (IQR 0-8) for patients with neither disease (p<0.0001). In multivariate regression analysis adjusted for age, sex, and congestive heart failure (CHF), the presence of B-lines (OR = 1.29, 95% CI 1.09-1.53) was independently associated with COVID-19 diagnosis. The presence of pleural effusion was inversely associated with COVID-19 (OR = 0.09, 95% CI 0.01-0.65). LUS may help providers preferentially identify the presence of influenza versus COVID-19 infection both visually and by calculating a modified Soldati score. Further studies assessing the utility of LUS in differentiating viral illnesses in patients with variable illness patterns and those with variable illness severity are warranted.
- 1 October 2021
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 48, 342-344
Do scan numbers predict point-of-care ultrasound use and accuracy in senior emergency medicine residents?
- 1 October 2021
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 48, 342-344
Do scan numbers predict point-of-care ultrasound use and accuracy in senior emergency medicine residents?
- 1 September 2020
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 38 (9) , 1792-1795
Ultrasound-guided transgluteal sciatic nerve analgesia for refractory back pain in the ED
- 1 September 2020
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 38 (9) , 1792-1795
Ultrasound-guided transgluteal sciatic nerve analgesia for refractory back pain in the ED
- 1 July 2019
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 37 (7) , 1372-1374
Faculty opinions concerning ultrasound utilization in the emergency department
- 1 July 2019
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 37 (7) , 1372-1374
Faculty opinions concerning ultrasound utilization in the emergency department
- 1 December 2018
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 36 (12) , 2325-2326
INSPIRED: Instruction of sonographic placement of IVs by registered nurses in the emergency department
- 1 December 2018
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 36 (12) , 2325-2326
INSPIRED: Instruction of sonographic placement of IVs by registered nurses in the emergency department
- 1 June 2008
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 26 (5) , 523-531
The new and old definitions of acute myocardial infarction: a data-based comparison
- 1 June 2008
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 26 (5) , 523-531
The new and old definitions of acute myocardial infarction: a data-based comparison